Herpes simplex-virusinfektion hos nyfødte

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Herpes simplex-virusinfektion hos nyfødte. / Lund, Stine; Henriksen, Tine Brink; Poulsen, Anja; Dungu, Kia Hee Schultz; Carlsen, Emma Louise Malchau; Hansen, Bo Mølholm; Aunsholt, Lise; Nygaard, Ulrikka.

I: Ugeskrift for Laeger, Bind 184, Nr. 24, V11210869, 2022.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Lund, S, Henriksen, TB, Poulsen, A, Dungu, KHS, Carlsen, ELM, Hansen, BM, Aunsholt, L & Nygaard, U 2022, 'Herpes simplex-virusinfektion hos nyfødte', Ugeskrift for Laeger, bind 184, nr. 24, V11210869. <https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-06/v11120869_web.pdf>

APA

Lund, S., Henriksen, T. B., Poulsen, A., Dungu, K. H. S., Carlsen, E. L. M., Hansen, B. M., Aunsholt, L., & Nygaard, U. (2022). Herpes simplex-virusinfektion hos nyfødte. Ugeskrift for Laeger, 184(24), [V11210869]. https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-06/v11120869_web.pdf

Vancouver

Lund S, Henriksen TB, Poulsen A, Dungu KHS, Carlsen ELM, Hansen BM o.a. Herpes simplex-virusinfektion hos nyfødte. Ugeskrift for Laeger. 2022;184(24). V11210869.

Author

Lund, Stine ; Henriksen, Tine Brink ; Poulsen, Anja ; Dungu, Kia Hee Schultz ; Carlsen, Emma Louise Malchau ; Hansen, Bo Mølholm ; Aunsholt, Lise ; Nygaard, Ulrikka. / Herpes simplex-virusinfektion hos nyfødte. I: Ugeskrift for Laeger. 2022 ; Bind 184, Nr. 24.

Bibtex

@article{0d3460aef75947599dffa144f5f4ccc7,

title = "Herpes simplex-virusinfektion hos nyf{\o}dte",

abstract = "Neonatal herpes simplex disease (HSV) is a rare but life-threatening infection associated with high rates of morbidity and mortality. Recent studies indicate that the incidence rate has continued to rise over the past decades, while the mortality remains unchanged. Early clinical suspicion of HSV and parenteral antiviral treatment of acute disease is essential for the prognosis. The subsequent use of suppressive therapy with oral acyclovir has further enhanced the long-term prognosis. This review presents evidence of risk factors, clinical presentation, prevention, and management of HSV in newborns.",

keywords = "Acyclovir/therapeutic use, Antiviral Agents, Female, Herpes Simplex/diagnosis, Humans, Incidence, Infant, Newborn, Pregnancy, Pregnancy Complications, Infectious/prevention & control, Prognosis",

author = "Stine Lund and Henriksen, {Tine Brink} and Anja Poulsen and Dungu, {Kia Hee Schultz} and Carlsen, {Emma Louise Malchau} and Hansen, {Bo M{\o}lholm} and Lise Aunsholt and Ulrikka Nygaard",

year = "2022",

language = "Dansk",

volume = "184",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "24",

}

RIS

TY - JOUR

T1 - Herpes simplex-virusinfektion hos nyfødte

AU - Lund, Stine

AU - Henriksen, Tine Brink

AU - Poulsen, Anja

AU - Dungu, Kia Hee Schultz

AU - Carlsen, Emma Louise Malchau

AU - Hansen, Bo Mølholm

AU - Aunsholt, Lise

AU - Nygaard, Ulrikka

PY - 2022

Y1 - 2022

N2 - Neonatal herpes simplex disease (HSV) is a rare but life-threatening infection associated with high rates of morbidity and mortality. Recent studies indicate that the incidence rate has continued to rise over the past decades, while the mortality remains unchanged. Early clinical suspicion of HSV and parenteral antiviral treatment of acute disease is essential for the prognosis. The subsequent use of suppressive therapy with oral acyclovir has further enhanced the long-term prognosis. This review presents evidence of risk factors, clinical presentation, prevention, and management of HSV in newborns.

AB - Neonatal herpes simplex disease (HSV) is a rare but life-threatening infection associated with high rates of morbidity and mortality. Recent studies indicate that the incidence rate has continued to rise over the past decades, while the mortality remains unchanged. Early clinical suspicion of HSV and parenteral antiviral treatment of acute disease is essential for the prognosis. The subsequent use of suppressive therapy with oral acyclovir has further enhanced the long-term prognosis. This review presents evidence of risk factors, clinical presentation, prevention, and management of HSV in newborns.

KW - Acyclovir/therapeutic use

KW - Antiviral Agents

KW - Female

KW - Herpes Simplex/diagnosis

KW - Humans

KW - Incidence

KW - Infant, Newborn

KW - Pregnancy

KW - Pregnancy Complications, Infectious/prevention & control

KW - Prognosis

M3 - Review

C2 - 35703071

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 24

M1 - V11210869

ER -

ID: 329700299